The Lmo2 Oncogene Initiates Leukemia in Mice by Inducing Thymocyte Self-Renewal

被引:190
作者
McCormack, Matthew P. [1 ,2 ]
Young, Lauren F. [1 ]
Vasudevan, Sumitha [1 ]
de Graaf, Carolyn A. [3 ,4 ]
Codrington, Rosalind [5 ]
Rabbitts, Terence H. [5 ]
Jane, Stephen M. [1 ,2 ]
Curtis, David J. [1 ,2 ]
机构
[1] Royal Melbourne Hosp, Rotary Bone Marrow Res Labs, Parkville, Vic 3050, Australia
[2] Univ Melbourne, Dept Med, Parkville, Vic 3010, Australia
[3] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia
[4] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia
[5] St James Univ Hosp, Leeds Inst Mol Med, Leeds LS9 7TF, W Yorkshire, England
基金
英国医学研究理事会;
关键词
ACUTE LYMPHOBLASTIC-LEUKEMIA; T-CELL LEUKEMIA; GENE-THERAPY; CHROMOSOMAL TRANSLOCATIONS; RETROVIRAL INSERTION; PROTEIN RBTN2; SCID-X1; HEMATOPOIESIS; TRANSCRIPTION; ACTIVATION;
D O I
10.1126/science.1182378
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The LMO2 oncogene causes a subset of human T cell acute lymphoblastic leukemias (T-ALL), including four cases that arose as adverse events in gene therapy trials. To investigate the cellular origin of LMO2-induced leukemia, we used cell fate mapping to study mice in which the Lmo2 gene was constitutively expressed in the thymus. Lmo2 induced self-renewal of committed T cells in the mice more than 8 months before the development of overt T-ALL. These self-renewing cells retained the capacity for T cell differentiation but expressed several genes typical of hematopoietic stem cells (HSCs), suggesting that Lmo2 might reactivate an HSC-specific transcriptional program. Forced expression of one such gene, Hhex, was sufficient to initiate self-renewal of thymocytes in vivo. Thus, Lmo2 promotes the self-renewal of preleukemic thymocytes, providing a mechanism by which committed T cells can then accumulate additional genetic mutations required for leukemic transformation.
引用
收藏
页码:879 / 883
页数:5
相关论文
共 18 条
[1]   Molecular pathogenesis of T-cell leukaemia and lymphoma [J].
Aifantis, Iannis ;
Raetz, Elizabeth ;
Buonamici, Silvia .
NATURE REVIEWS IMMUNOLOGY, 2008, 8 (05) :380-390
[2]   Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia [J].
Ferrando, AA ;
Neuberg, DS ;
Staunton, J ;
Loh, ML ;
Huard, C ;
Raimondi, SC ;
Behm, FG ;
Pui, CH ;
Downing, JR ;
Gilliland, DG ;
Lander, ES ;
Golub, TR ;
Look, AT .
CANCER CELL, 2002, 1 (01) :75-87
[3]   LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1 [J].
Hacein-Bey-Abina, S ;
Von Kalle, C ;
Schmidt, M ;
McCcormack, MP ;
Wulffraat, N ;
Leboulch, P ;
Lim, A ;
Osborne, CS ;
Pawliuk, R ;
Morillon, E ;
Sorensen, R ;
Forster, A ;
Fraser, P ;
Cohen, JI ;
de Saint Basile, G ;
Alexander, I ;
Wintergerst, U ;
Frebourg, T ;
Aurias, A ;
Stoppa-Lyonnet, D ;
Romana, S ;
Radford-Weiss, I ;
Gross, F ;
Valensi, F ;
Delabesse, E ;
Macintyre, E ;
Sigaux, F ;
Soulier, J ;
Leiva, LE ;
Wissler, M ;
Prinz, C ;
Rabbitts, TH ;
Le Deist, F ;
Fischer, A ;
Cavazzana-Calvo, M .
SCIENCE, 2003, 302 (5644) :415-419
[4]   Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1 [J].
Hacein-Bey-Abina, Salima ;
Garrigue, Alexandrine ;
Wang, Gary P. ;
Soulier, Jean ;
Lim, Annick ;
Morillon, Estelle ;
Clappier, Emmanuelle ;
Caccavelli, Laure ;
Delabesse, Eric ;
Beldjord, Kheira ;
Asnafi, Vahid ;
Macintyre, Elizabeth ;
Dal Cortivo, Liliane ;
Radford, Isabelle ;
Brousse, Nicole ;
Sigaux, Francois ;
Moshous, Despina ;
Hauer, Julia ;
Borkhardt, Arndt ;
Belohradsky, Bernd H. ;
Wintergerst, Uwe ;
Velez, Maria C. ;
Leiva, Lily ;
Sorensen, Ricardo ;
Wulffraat, Nicolas ;
Blanche, Stephane ;
Bushman, Frederic D. ;
Fischer, Alain ;
Cavazzana-Calvo, Marina .
JOURNAL OF CLINICAL INVESTIGATION, 2008, 118 (09) :3132-3142
[5]   The critical regulator of embryonic hematopoiesis, SCL, is vital in the adult for megakaryopoiesis, erythropoiesis, and lineage choice in CFU-S12 [J].
Hall, MA ;
Curtis, DJ ;
Metcalf, D ;
Elefanty, AG ;
Sourris, K ;
Robb, L ;
Göthert, JR ;
Jane, SM ;
Begley, CG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (03) :992-997
[6]   Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients [J].
Howe, Steven J. ;
Mansour, Marc R. ;
Schwarzwaelder, Kerstin ;
Bartholomae, Cynthia ;
Hubank, Michael ;
Kempski, Helena ;
Brugman, Martijn H. ;
Pike-Overzet, Karin ;
Chatters, Stephen J. ;
de Ridder, Dick ;
Gilmour, Kimberly C. ;
Adams, Stuart ;
Thornhill, Susannah I. ;
Parsley, Kathryn L. ;
Staal, Frank J. T. ;
Gale, Rosemary E. ;
Linch, David C. ;
Bayford, Jinhua ;
Brown, Lucie ;
Quaye, Michelle ;
Kinnon, Christine ;
Ancliff, Philip ;
Webb, David K. ;
Schmidt, Manfred ;
von Kalle, Christof ;
Gaspar, H. Bobby ;
Thrasher, Adrian J. .
JOURNAL OF CLINICAL INVESTIGATION, 2008, 118 (09) :3143-3150
[7]  
LARSON RC, 1995, ONCOGENE, V11, P853
[8]  
LARSON RC, 1994, ONCOGENE, V9, P3675
[9]   Activation of the T-cell oncogene LMO2 after gene therapy for X-linked severe combined immunodeficiency [J].
McCormack, MP ;
Rabbitts, TH .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (09) :913-922
[10]   The LMO2 T-cell oncogene is activated via chromosomal translocations or retroviral insertion during gene therapy but has no mandatory role in normal T-cell development [J].
McCormack, MP ;
Forster, A ;
Drynan, L ;
Pannell, R ;
Rabbitts, TH .
MOLECULAR AND CELLULAR BIOLOGY, 2003, 23 (24) :9003-9013